These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10094138)

  • 41. Inhibition of cholinesterase elicits muscarinic receptor-mediated synaptic transmission in the rat adrenal medulla.
    Akiyama T; Yamazaki T; Mori H; Sunagawa K
    Auton Neurosci; 2003 Sep; 107(2):65-73. PubMed ID: 12963416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of M1 and CB₁ receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex.
    Fogaça MV; Fedoce AG; Ferreira-Junior NC; Guimarães FS; Resstel LB
    Psychopharmacology (Berl); 2016 Apr; 233(8):1377-85. PubMed ID: 26873081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of M3 muscarinic receptors of the spinal cord in formalin-induced nociception in mice.
    Honda K; Harada A; Takano Y; Kamiya H
    Brain Res; 2000 Mar; 859(1):38-44. PubMed ID: 10720613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of the activity of hippocampal stratum oriens interneurons by alpha7 nicotinic acetylcholine receptors.
    Buhler AV; Dunwiddie TV
    Neuroscience; 2001; 106(1):55-67. PubMed ID: 11564416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different properties of the bradycardia produced by neostigmine and edrophonium in the cat.
    Backman SB; Stein RD; Blank DW; Collier B; Polosa C
    Can J Anaesth; 1996 Jul; 43(7):731-40. PubMed ID: 8807181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory effects of cholinergic agents on the release of transmitter at the frog neuromuscular junction.
    Duncan CJ; Publicover SJ
    J Physiol; 1979 Sep; 294():91-103. PubMed ID: 229216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synaptic inhibitory effects of edrophonium on sympathetic ganglionic transmission.
    Stein RD; Backman SB; Collier B; Polosa C
    Can J Anaesth; 1998 Oct; 45(10):1011-8. PubMed ID: 9836039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological characterization of adrenal paraneurons: substance P and somatostatin as inhibitory modulators of the nicotinic response.
    Mizobe F; Kozousek V; Dean DM; Livett BG
    Brain Res; 1979 Dec; 178(2-3):555-66. PubMed ID: 509217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors.
    Boksa P; Quik M; Mitchell JB; Collier B; O'Neil W; Quirion R
    Eur J Pharmacol; 1989 Nov; 173(1):93-108. PubMed ID: 2606158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition.
    Acquas E; Fibiger HC
    J Neurochem; 1998 Mar; 70(3):1088-93. PubMed ID: 9489729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological differences between rat frontal cortex and hippocampus in the nicotinic modulation of noradrenaline release implicate distinct receptor subtypes.
    Kennett A; Heal DJ; Wonnacott S
    Nicotine Tob Res; 2012 Nov; 14(11):1339-45. PubMed ID: 22614547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans.
    Mazza E; Ghigo E; Boffano G; Valetto M; Maccario M; Arvat E; Bellone J; Procopio M; Müller EE; Camanni F
    Eur J Pharmacol; 1994 Mar; 254(1-2):17-20. PubMed ID: 8206111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of choline on basal and stimulated acetylcholine release: an in vivo microdialysis study using a low neostigmine concentration.
    Marshall DL; Wurtman RJ
    Brain Res; 1993 Dec; 629(2):269-74. PubMed ID: 8111630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Muscarinic receptor modulation of GABA-mediated giant depolarizing potentials in the neonatal rat hippocampus.
    Avignone E; Cherubini E
    J Physiol; 1999 Jul; 518(Pt 1):97-107. PubMed ID: 10373692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypothalamic cholinergic regulation of body temperature and water intake in rats.
    Takahashi A; Ishimaru H; Ikarashi Y; Kishi E; Maruyama Y
    Auton Neurosci; 2001 Dec; 94(1-2):74-83. PubMed ID: 11775710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex differences in cholinergic analgesia II: differing mechanisms in two models of allodynia.
    Lavand'homme PM; Eisenach JC
    Anesthesiology; 1999 Nov; 91(5):1455-61. PubMed ID: 10551598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central cholinergic transmission affects the compulsive-like behavior of mice in marble-burying test.
    Patel C; Patel R; Maturkar V; Jain NS
    Brain Res; 2024 Feb; 1825():148713. PubMed ID: 38097126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord.
    Naguib M; Yaksh TL
    Anesth Analg; 1997 Oct; 85(4):847-53. PubMed ID: 9322468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low sensitivity of adrenal chromaffin cells to acetylcholine, neostigmine and oxotremorine in 21-day-old rats.
    Fujino Y; Fujii T
    Jpn J Pharmacol; 1997 Oct; 75(2):145-53. PubMed ID: 9414029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The M1 antagonist pirenzepine suppresses heterosynaptic STD in the CA1 region.
    Kozhemyakin MB; Kleschevnikov AM
    Neuroreport; 1994 Aug; 5(13):1670-2. PubMed ID: 7819544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.